Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
4.90
Dollar change
-0.19
Percentage change
-3.73
%
Index- P/E- EPS (ttm)-1.92 Insider Own26.30% Shs Outstand51.65M Perf Week5.38%
Market Cap253.43M Forward P/E- EPS next Y-1.85 Insider Trans3.03% Shs Float38.11M Perf Month0.20%
Income-82.44M PEG- EPS next Q-0.43 Inst Own69.42% Short Float4.76% Perf Quarter63.88%
Sales0.00M P/S- EPS this Y7.98% Inst Trans0.10% Short Ratio3.02 Perf Half Y70.73%
Book/sh2.26 P/B2.17 EPS next Y-7.17% ROA-52.37% Short Interest1.81M Perf Year169.23%
Cash/sh2.54 P/C1.93 EPS next 5Y- ROE-70.94% 52W Range1.43 - 6.85 Perf YTD74.38%
Dividend Est.- P/FCF- EPS past 5Y-49.79% ROI-59.34% 52W High-28.47% Beta2.65
Dividend TTM- Quick Ratio6.82 Sales past 5Y0.00% Gross Margin- 52W Low242.66% ATR (14)0.43
Dividend Ex-Date- Current Ratio6.82 EPS Y/Y TTM23.34% Oper. Margin0.00% RSI (14)54.03 Volatility11.17% 9.34%
Employees54 Debt/Eq0.22 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price10.60
Option/ShortYes / Yes LT Debt/Eq0.19 EPS Q/Q35.12% Payout- Rel Volume0.67 Prev Close5.09
Sales Surprise- EPS Surprise27.04% Sales Q/Q- EarningsMar 12 BMO Avg Volume599.92K Price4.90
SMA205.19% SMA5016.65% SMA20048.56% Trades Volume403,015 Change-3.73%
Date Action Analyst Rating Change Price Target Change
Jul-14-23Initiated Piper Sandler Overweight
Jun-30-23Upgrade Stifel Hold → Buy $2 → $10
Jun-28-23Upgrade H.C. Wainwright Neutral → Buy $11
Jun-27-23Upgrade Wedbush Neutral → Outperform $10
Mar-29-22Downgrade Wedbush Outperform → Neutral
Mar-22-22Downgrade H.C. Wainwright Buy → Neutral
Sep-30-21Initiated Stifel Hold $10
Jan-07-21Initiated Wedbush Outperform $45
Nov-24-20Initiated Berenberg Buy $58
May-04-20Initiated H.C. Wainwright Buy $53
Mar-22-24 09:55AM
Mar-14-24 05:31AM
Mar-12-24 08:32AM
08:00AM
Mar-05-24 04:30PM
08:00AM Loading…
Feb-28-24 08:00AM
Jan-04-24 08:00AM
Dec-13-23 07:00AM
Nov-07-23 08:00AM
Nov-06-23 08:07AM
07:48AM
07:45AM
Oct-20-23 12:54PM
Oct-14-23 12:30PM
Oct-04-23 12:14PM
12:34PM Loading…
Sep-18-23 12:34PM
07:00AM
Sep-11-23 08:00AM
Sep-05-23 08:00AM
Aug-17-23 09:56AM
Aug-11-23 07:35AM
07:30AM
Jul-25-23 07:43AM
Jul-16-23 10:05AM
Jun-29-23 08:57PM
05:48PM
Jun-28-23 04:23PM
07:15AM
Jun-27-23 07:00AM
Jun-13-23 08:00AM
08:00AM Loading…
Jun-02-23 08:00AM
May-18-23 10:17AM
May-09-23 07:46AM
07:30AM
Apr-18-23 08:00AM
Apr-17-23 04:01PM
Mar-09-23 07:52AM
07:30AM
Feb-27-23 08:00AM
Feb-15-23 05:46AM
Jan-19-23 05:41AM
Jan-05-23 08:00AM
Dec-19-22 08:00AM
Dec-12-22 08:00AM
Dec-09-22 09:35AM
09:04AM
Nov-09-22 08:00AM
Nov-08-22 08:00AM
Oct-26-22 08:00AM
Sep-06-22 08:00AM
Aug-28-22 09:41AM
Aug-09-22 08:00AM
Aug-03-22 08:00AM
Aug-01-22 08:55AM
Jul-02-22 08:29AM
Jun-06-22 08:00AM
Jun-01-22 07:00AM
May-17-22 07:00AM
May-12-22 04:30PM
May-11-22 04:30PM
Apr-28-22 12:52PM
Apr-25-22 09:00AM
Apr-18-22 07:00AM
Apr-07-22 04:30PM
07:00AM
Mar-17-22 05:00PM
Mar-02-22 08:00AM
Feb-22-22 08:00AM
Feb-16-22 05:28AM
Jan-11-22 07:00AM
Jan-10-22 07:00AM
Jan-05-22 08:00AM
Nov-18-21 05:27AM
Nov-08-21 04:05PM
07:45AM
Oct-08-21 04:05PM
Oct-04-21 11:02AM
Sep-30-21 04:35PM
Sep-21-21 04:05PM
07:45AM
Aug-12-21 08:22AM
Aug-10-21 07:45AM
Aug-04-21 07:45AM
Aug-02-21 02:26AM
Jul-29-21 03:53PM
May-19-21 05:00PM
May-17-21 07:45AM
May-07-21 07:45AM
May-04-21 02:01AM
Apr-28-21 10:38AM
Apr-10-21 08:30AM
Mar-25-21 07:45AM
Mar-10-21 04:58PM
Mar-02-21 04:05PM
Feb-23-21 07:45AM
Feb-11-21 04:15PM
Feb-02-21 11:51PM
07:32PM
Jan-20-21 07:45AM
Jan-05-21 07:45AM
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH GROWTH N V10% OwnerOct 17 '23Buy2.34400,000934,0808,517,839Oct 19 03:08 PM
Behbahani AliDirectorJul 05 '23Buy5.001,000,0005,000,0004,448,757Jul 06 04:45 PM
RA CAPITAL MANAGEMENT, L.P.DirectorJul 05 '23Buy5.00935,8504,679,2503,213,828Jul 07 04:30 PM
BIOTECH GROWTH N V10% OwnerJun 30 '23Buy5.001,000,0005,000,0008,117,839Jul 03 03:36 PM
BIOTECH GROWTH N V10% OwnerJun 27 '23Buy5.491,740,0009,555,0367,117,839Jun 29 01:37 PM
Epstein David M.SEE REMARKSJun 27 '23Sale6.7025,000167,500671,423Jun 28 04:02 PM